ranolazine
Generic: ranolazine
Labeler: zydus lifesciences limitedDrug Facts
Product Profile
Brand Name
ranolazine
Generic Name
ranolazine
Labeler
zydus lifesciences limited
Dosage Form
TABLET, EXTENDED RELEASE
Routes
Active Ingredients
ranolazine 1000 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
70771-1500
Product ID
70771-1500_b80bd37e-952a-4a30-9b48-6dca616f181d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210188
Listing Expiration
2027-12-31
Marketing Start
2019-09-10
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
707711500
Hyphenated Format
70771-1500
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ranolazine (source: ndc)
Generic Name
ranolazine (source: ndc)
Application Number
ANDA210188 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1000 mg/1
Packaging
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1500-1)
- 10 BLISTER PACK in 1 CARTON (70771-1500-4) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70771-1500-2)
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1500-5)
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1500-6)
Packages (4)
70771-1500-1
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1500-1)
70771-1500-4
10 BLISTER PACK in 1 CARTON (70771-1500-4) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70771-1500-2)
70771-1500-5
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1500-5)
70771-1500-6
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1500-6)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b80bd37e-952a-4a30-9b48-6dca616f181d", "openfda": {"nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "unii": ["A6IEZ5M406"], "rxcui": ["616749", "728231"], "spl_set_id": ["d74f3dea-7357-4e9a-be9a-2f498a44108a"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1500-1)", "package_ndc": "70771-1500-1", "marketing_start_date": "20190910"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (70771-1500-4) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70771-1500-2)", "package_ndc": "70771-1500-4", "marketing_start_date": "20190910"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1500-5)", "package_ndc": "70771-1500-5", "marketing_start_date": "20190910"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1500-6)", "package_ndc": "70771-1500-6", "marketing_start_date": "20190910"}], "brand_name": "Ranolazine", "product_id": "70771-1500_b80bd37e-952a-4a30-9b48-6dca616f181d", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-anginal [EPC]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "70771-1500", "generic_name": "Ranolazine", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ranolazine", "active_ingredients": [{"name": "RANOLAZINE", "strength": "1000 mg/1"}], "application_number": "ANDA210188", "marketing_category": "ANDA", "marketing_start_date": "20190910", "listing_expiration_date": "20271231"}